Tag: UK Pharma

Grey Wolf to Fund Development of Therapy Increasing Tumour Visibility

Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. Grey Wolf Therapeutics, a drug discovery ...

No-Deal Brexit Could Lead to Fake Med in UK

Drugmakers warned on Friday that if Britain leaves the European Union without a deal next month Britons could miss out on an EU-wide system to fight counterfeit drugs that will go live on Saturday aft...

AI Drugs Should Be Regulated Better

Products based on artificial intelligence should be regulated like drugs, and those that are deemed unsafe should be removed from the market, according to a new report. The report commissioned by N...

SID&GP about MoU and Relatioship with UK

On January 29, the UK and Russia have signed a memorandum of understanding enhancing cooperation in the field of regulation of medicines. Radio Sputnik discussed the development with Nikolay Tsatsy...

Russia to Inspect British Pharma Manufacturers

The Russian Ministry of Industry and Trade’s State Institute of Drugs and Good Practices plans to inspect five British pharmaceutical manufacturers for compliance with GMP standards in 2019. That’s ac...

Validair Expands Securing £150k in Funding

Validair Monitoring Solutions Limited has secured over £150k in funding from the Midlands Engine Investment Fund. The investment will support the company’s growth across the UK due to escalating deman...

Sphere Fluidics to Extend its Single Cell Analysis System

The Cambridge university spin-off will use the funding to accelerate growth in global operations and support sales of its Cyto-Mine Single Cell analysis system. Sphere Fluidics has closed a US$2 mi...

UK Has Lack of Students Studying STEM Subjects

Highly skilled scientific roles could move elsewhere if the situation is not addressed as a matter of urgency. The Association of the British pharmaceutical industry, ABPI, has released "Bridging t...

UK and Russia’s Medicines Regulators Signed MoU

Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health. The Medicines and Healthcare products Regulatory Agency (MHRA) has signe...

Novartis Statement Regarding No-Deal Brexit

Novartis has issued a statement expressing concern over the state of medicine supply to the UK, and noting that it is building increased inventories across its portfolio of medicines in the UK. The...

Destiny Pharma Got £1.6m to Examine XF Drugs for Superbugs

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, that addresses the global problem of antimicrobial resistance (AMR), today announces it ...

No-Deal Brexit – Guidance for Clinical Trials

The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) released further guidance on the regulation of medicines, medical devices and clinical trials if there is no Brexit deal. The scenar...

UK Breakthrough Plan for AMR

A new reimbursement model for antibiotics by the NHS and NICE is being labelled as a ‘great breakthrough’. The model is part of the government’s new national action plan on how it will fight agains...

Almac Expands Facility for Personalised Cancer Vaccine

Contract development and manufacturing organisation (CDMO) The Almac Group has announced it is expanding its Edinburgh Technopole facility to help scale-up its personalised cancer vaccine activities. ...

New MMIC in Scotland

A new research, development and manufacturing facility for medicines is to be built in Scotland thanks to a partnership between the Centre for Process Innovation (CPI) and multiple partners. The Me...

UK Researcher to Fight Opioid Addiction

A UK university has been awarded £2.4 million to research overprescribing of opioids, and how to improve treatment of patients with persistent pain without long-term use of these morphine-like drugs. ...